BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25722435)

  • 1. SORTILIN: many headed hydra.
    Westerterp M; Tall AR
    Circ Res; 2015 Feb; 116(5):764-6. PubMed ID: 25722435
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
    Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
    Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
    Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ
    Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catch and Release: NG2-Coated Vascular Smooth Muscle Cells Capture Lipoproteins for Macrophages.
    Fogelstrand P; Borén J
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):7-8. PubMed ID: 26700135
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis.
    Gleissner CA; Leitinger N; Ley K
    Hypertension; 2007 Aug; 50(2):276-83. PubMed ID: 17548720
    [No Abstract]   [Full Text] [Related]  

  • 6. Sortilin: A novel regulator in lipid metabolism and atherogenesis.
    Zhong LY; Cayabyab FS; Tang CK; Zheng XL; Peng TH; Lv YC
    Clin Chim Acta; 2016 Sep; 460():11-7. PubMed ID: 27312323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron-autoradiographic and biochemical study of the role of foam cells in low density lipoprotein metabolism].
    Popov AV; Vinogradov AG; Nadtochiĭ VV
    Vopr Med Khim; 1978; 24(1):109-13. PubMed ID: 208292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the study of lipoprotein metabolism and atherosclerosis: mechanism of foam cell transformation of macrophages--with special reference to oxidized LDL].
    Yokode M; Kita T; Kawai C
    Nihon Rinsho; 1988 Mar; 46(3):652-8. PubMed ID: 3404691
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose.
    Hayek T; Hussein K; Aviram M; Coleman R; Keidar S; Pavoltzky E; Kaplan M
    Atherosclerosis; 2005 Nov; 183(1):25-33. PubMed ID: 16216589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of foam cell transformation of macrophages].
    Kita T
    Seikagaku; 1988 Oct; 60(10):1163-8. PubMed ID: 3249073
    [No Abstract]   [Full Text] [Related]  

  • 11. How do macrophages sense modified low-density lipoproteins?
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Mar; 230():232-240. PubMed ID: 28052815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
    Wang P; He LY; Shen GD; Li RL; Yang JL
    Inflammopharmacology; 2017 Dec; 25(6):633-642. PubMed ID: 28365854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonate metabolism during foam cell transformation of macrophages.
    Yokode M; Kita T; Narumiya S; Kawai C
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():229-32. PubMed ID: 2959054
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid droplet-associated proteins in atherosclerosis (Review).
    Plakkal Ayyappan J; Paul A; Goo YH
    Mol Med Rep; 2016 Jun; 13(6):4527-34. PubMed ID: 27082419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro.
    Rashid I; van Reyk DM; Davies MJ
    FEBS Lett; 2007 Mar; 581(5):1067-70. PubMed ID: 17316626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein: a double-edged sword on atherosclerosis.
    Yu BL; Zhao SP; Huang XS
    Med Hypotheses; 2007; 69(3):553-6. PubMed ID: 17368957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
    She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake of a dexamethasone palmitate-low density lipoprotein complex by macrophages and foam cells.
    Tauchi Y; Chono S; Morimoto K
    J Drug Target; 2003 Apr; 11(3):163-8. PubMed ID: 14577972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of FXR in foam-cell formation and atherosclerosis development.
    Guo GL; Santamarina-Fojo S; Akiyama TE; Amar MJ; Paigen BJ; Brewer B; Gonzalez FJ
    Biochim Biophys Acta; 2006 Dec; 1761(12):1401-9. PubMed ID: 17110163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.